Literature DB >> 24371622

A case of endometrial cancer in the context of a BRCA2 mutation and double heterozygosity for Lynch syndrome.

Ping Gong1, Sarah Charles2, Norman Rosenblum3, Zoe Wang1, Agnieszka K Witkiewicz1.   

Abstract

Endometrial cancer with BRCA2 mutation and double heterozygosity for Lynch syndrome. ► Loss of MLH1 and PMS2 by immunohistochemical stain. ► MSH1 and MSH6 gene mutations by genomic sequencing.

Entities:  

Keywords:  BRCA2 mutation; Double heterozygosity; Endometrial cancer; Lynch syndrome

Year:  2012        PMID: 24371622      PMCID: PMC3860713          DOI: 10.1016/j.gynor.2012.03.001

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN: 2211-338X


  10 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability.

Authors:  H Yamamoto; F Itoh; H Nakamura; H Fukushima; S Sasaki; M Perucho; K Imai
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

3.  Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.

Authors:  Aziz Zaanan; Katy Meunier; Fatiha Sangar; Jean-François Fléjou; Françoise Praz
Journal:  Cell Oncol (Dordr)       Date:  2011-04-12       Impact factor: 6.730

4.  A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families.

Authors:  Kathleen Y Yang; Aaron B Caughey; Sarah E Little; Michael K Cheung; Lee-May Chen
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

5.  Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.

Authors:  Maran J W Berends; Ying Wu; Rolf H Sijmons; Rob G J Mensink; Tineke van der Sluis; Jannet M Hordijk-Hos; Elisabeth G E de Vries; Harry Hollema; Arend Karrenbeld; Charles H C M Buys; Ate G J van der Zee; Robert M W Hofstra; Jan H Kleibeuker
Journal:  Am J Hum Genet       Date:  2002-01       Impact factor: 11.025

Review 6.  DNA mismatch repair deficiency in endometrial carcinoma.

Authors:  Yevgeniy Karamurzin; Joanne K L Rutgers
Journal:  Int J Gynecol Pathol       Date:  2009-05       Impact factor: 2.762

7.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

Review 8.  Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.

Authors:  Kimberly E Resnick; Heather Hampel; Richard Fishel; David E Cohn
Journal:  Gynecol Oncol       Date:  2009-04-17       Impact factor: 5.482

9.  Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes.

Authors:  Margaret Smith; Susan Fawcett; Emanouil Sigalas; Richard Bell; Sophie Devery; Nikolina Andrieska; Ingrid Winship
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

10.  Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Authors:  I Thiffault; N Hamel; T Pal; S McVety; V A Marcus; D Farber; S Cowie; J Deschênes; W Meschino; F Odefrey; D Goldgar; T Graham; S Narod; A K Watters; E MacNamara; D Du Sart; G Chong; W D Foulkes
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  10 in total
  4 in total

1.  Letter to the editor: mistaken inheritance.

Authors:  Kory Jasperson; Lori Ballinger
Journal:  Int J Colorectal Dis       Date:  2015-04-07       Impact factor: 2.571

2.  Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.

Authors:  Monika Morak; Sarah Käsbauer; Martina Kerscher; Andreas Laner; Anke M Nissen; Anna Benet-Pagès; Hans K Schackert; Gisela Keller; Trisari Massdorf; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

3.  Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations.

Authors:  Hagit Shani; Rinat Bernstein-Molho; Yael Laitman; Iris Netzer; Eitan Friedman
Journal:  Breast Cancer Res Treat       Date:  2021-01-15       Impact factor: 4.872

4.  An Individual with Both MUTYH-Associated Polyposis and Lynch Syndrome Identified by Multi-Gene Hereditary Cancer Panel Testing: A Case Report.

Authors:  Stephanie A Cohen; Christopher A Tan; Ryan Bisson
Journal:  Front Genet       Date:  2016-03-16       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.